Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative)

v3.21.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative)
 1 Months Ended 3 Months Ended
Apr. 08, 2020
USD ($)
Number
$ / shares
shares
Jan. 31, 2020
USD ($)
shares
Feb. 28, 2021
USD ($)
$ / shares
shares
Dividend payable     $ 600,000
Conversion price | $ / shares $ 0.15    
Number of shares converted (in shares) | shares 33,333    
Value of converted shares $ 5,000    
Decription of conversion     Holders may convert their shares of Series A Preferred Stock into common stock at any time and the Company has the right to cause each holder to convert their shares of Series A Preferred Stock at any time after the eighteen (18) month anniversary of the original issue date if the common stock has traded for more than twenty (20) consecutive trading days above $0.50 (as adjusted for stock splits, stock dividends and similar transactions).
Warrant exercises     $ 134,000
Number of warrant issued for consultant for marketing services | shares     150,000
Accrued interest satisfied by issuance of warrants     $ 125,000
Exercise price of warrants | $ / shares     $ 0.25
Series A Preferred Stock [Member]      
Conversion price | $ / shares $ 0.15    
Series A Preferred Stock [Member]      
Number of shares issued | shares 1,391    
Value of shares issued $ 11,600,000    
Issue costs $ 29,150    
Fair value per share | $ / shares $ 8,333    
Debt Instrument, Face Amount $ 7,000,000    
Series A Preferred Stock [Member]      
Share issue price | $ / shares $ 5,000    
Percentage of dividend accured 10.00%    
Consecutive trading days | Number 20    
Description of voting rights Holders of shares of Series A Preferred Stock are not entitled to vote with the holders of common stock, however, for so long as there are 423 shares of Series A Preferred Stock outstanding, the Company is required to obtain the consent of the holders of the Series A Preferred Stock to take certain corporate actions, including to incur indebtedness in excess of $250,000 in the aggregate.    
Common Shares [Member]      
Market price | $ / shares $ 0.25    
Warrant exercises     $ 1,000
Warrant exercises (in shares) | shares     534,194
Convertible Noteholders [Member]      
Debt Instrument, Face Amount     $ 125,000
Warrants granted | shares   498,418 498,418
Accrued interest satisfied by issuance of warrants   $ 100,000  
Exercise price of warrants | $ / shares     $ 0.25
Warrants issued to note holders for every $1,000 of accrued interest | shares     4,000
Warrants granted, exercisable period     3 years 9 months 18 days